濮阳东方看男科病专不专业(濮阳东方妇科医院做人流口碑非常高) (今日更新中)

OCEANSIDE, Calif. (KGTV) - Therapy dogs are tasked with healing patients who are up against diversity. But two who walk the halls of Tri-City Medical Center have their own stories of survival."I think every one of us, animal or human, has our own story. We all have our trials and tribulations. And so I think having animals that have been through some difficult times helps them relate with our patients in a much more profound way," said Aaron Byzak, Chief External Affairs Officer for Tri-City Medical Center.Two veterans of the Pet Therapy Program are Prince the poodle and Calamity Jane the golden retriever, one a cancer survivor and the other a trauma survivor. "She's a very strong, strong, little pup, she's got a mind of her own," said Shar Pauley, who rescued Calamity Jane. "And she tells me which rooms she'd like to visit. Sometimes she'll walk down that hallway and then she'll stop and say I think this person needs a visit." The program has been comforting patients for over 20 years now."He's had nine lives, and I think part of his motivation for giving back is he just loves to work, and he loves people," said Mary Gleisberg, Prince's owner. The dogs must go through a rigorous process to earn their badge and must receive a bath before walking their rounds in the hospital. 1304

On Monday morning, Pfizer announced that so far in Phase 3 trials, its COVID-19 vaccine candidate has been 90% effective in promoting protection against the virus. And while the announcement has many Americans seeing the light at the end of the tunnel, the pandemic is still far from over.Pfizer's announcement on Monday is an encouraging sign, as it means that the company is on track to file for Emergency Use Authorization for the vaccine in the coming weeks. It also keeps the U.S. on a timeline to have at least one vaccine approved and available for distribution by the end of 2021.But Monday's announcement does not mean a vaccine is imminent. Pfizer is currently mass-manufacturing its vaccine candidate in the event it does receive Emergency Use Authorization from the FDA, and hopes to have 100 million doses of the vaccine ready to ship by year's end. But even if Pfizer is able to fulfill that ambitious order by Dec. 31, it would only be able to vaccinate about one-third of everyone in the county.Once the initial vaccine order has been completed, it will need to be rationed for those who need it most — likely health care workers, essential employees and people in high-risk populations. While it is unclear who exactly will be eligible to receive the vaccine first, the Department of Health and Human Services (HHS) says the early distribution of a COVID-19 vaccine will be "constrained tightly" and will be "highly targeted" to "achieve coverage in priority populations."Eventually, the U.S. hopes to grant emergency use authorization to several vaccine candidates — many of which are currently in production on orders from the U.S. government. HHS hopes that by the middle of next year, several vaccines will be approved and widely available. But at that point, officials will run into a second major hurdle — vaccine skepticism.Skepticism about vaccines has been on the rise in recent years, fueled in part by the spread of misinformation online. In particular, baseless conspiracies linking vaccines to autism have spread on social media, eroding public confidence in medicine. In addition, polarized politics in the U.S. have led to speculation that government leaders will approve an unsafe or ineffective vaccine for political purposes.Vaccines are only effective if enough members of the public become inoculated against a virus — if a virus has nowhere to spread, it will eventually die out. But Gallup polling released in October shows that just 50% of Americans say they would receive a COVID-19 vaccine if it had been approved by the FDA and available at no cost — far below the threshold for herd immunity, according to many health experts.The Gallup polling is consistent with AP polling from earlier this year that also only found 50% willingness to take a COVID-19 vaccine.All the while, the final push for a COVID-19 vaccine will be occurring during what members of the White House coronavirus task force warn will be the most concerning and deadly period of the pandemic. The virus is currently spreading in the U.S. faster than it has at any other point during the pandemic, just as Americans are moving social gatherings indoors where the virus is more likely to spread.To be clear, health officials' efforts to develop a safe and effective COVID-19 is a momentous and historic achievement — approving a vaccine for emergency use by the end of the year would shatter all previous records for vaccine development. But while there may be light at the end of the tunnel, it may take several months — or years — to reach the end of the pandemic. 3586

ORLANDO, Fla. – Florida: home to green palms, sunny skies and long lines for early voting.“We're seeing a lot of people who were actively engaged,” said Dr. Larry Walker, a professor with the Department of Educational Leadership and Higher Education at the University of Central Florida, who specializes in race and voting rights.Dr. Walker said, looking at state data, he expects a higher Black voter turnout this year in Florida, a state where they account for 14% of eligible voters.“I think we're going to see increasingly more Black voters that didn't vote in 2016, weren't ready to vote, to vote in this election,” Dr. Walker said.But will they in other battleground states? Some Black voters wonder.“I think our culture doesn't vote enough,” said Wisconsin voter Raven Ewing.“To be honest, I don’t know,” said Florida voter Joanna Joseph. “I really don’t know.”American University decided to find out. Researchers there surveyed 1,200 Black voters in the battleground states of Florida, Georgia, North Carolina, Michigan, Pennsylvania and Wisconsin. What researchers found were differences that are generational.When it comes to how motivated they are to vote, older Black voters overwhelmingly say they will definitely vote, while only 29% of Black voters under the age of 30 said they would.Definitely Voting60+ years old - 78%30-59 years old - 62%18-29 years old - 29%Source: American University Black Swing Voters ProjectAmerican University’s Sam Fulwood III is a fellow at American University's Center for Congressional and Presidential Studies and one of the researchers involved in the Black Swing Voter Project.“The starkest difference of all of those different categories came along generational lines,” Fulwood said.How do Black voters in swing states feel about the candidates? That also differs by age, with support for former vice president Joe Biden higher among older Black voters than younger.Conversely, President Donald Trump’s support is higher among younger Black voters than older, though still in the single digits.Plan to Vote for Biden60+ years old – 86%30-59 years old – 70%18-29 years old – 47%Plan to Vote for Trump60+ years old – 4%30-59 years old – 7%18-29 years old – 8%Source: American University Black Swing Voters Project“Politicians, whether they're Democrats or Republicans, if they want to engage African-Americans, they're going to have to show some tangible benefits of political engagement that make them feel that there is a reason to participate in the system,” Fulwood said.Researchers say it is possible Sen. Kamala Harris’ historic run on the Democratic ticket, as a vice presidential candidate of Black and South Asian descent – along with her being an alumna of Howard University, one of the premier Historically Black College and Universities – could help bring some Black voters to the polls. Just how many are motivated to do so, remains to be seen. 2913

Often as long-winded and cumbersome as its title, "The Personal History of David Copperfield" sputters at times but manages to make you feel good while you're sort of bored.In many ways, it's the ideal pandemic movie. The timeless, Job-like tale follows a put-upon man who is subject to one ludicrously unfair situation, managing to thrive by maintaining his faith in himself.Director Armando Iannucci ("In the Loop," "The Death of Stalin") has a clear love for the 1850 Charles Dickens source material. Maybe he has too much reverence for every laborious twist and turn of the gigantic novel, which seems more comfortable in a miniseries format rather than a tight two-hour package.You could hardly dream up a better cast. Dev Patel thrives in the lead role as adult David, granting him a can-do attitude that makes him easy to get behind amid all the challenges he faces.Hugh Laurie is deliciously cantankerous as the ne'er do well Mr. Dick, and Tilda Swinton is regal as Betsey Trotwood, whose own riches-to-rags tale echoes that of David.The producers assembled a refreshingly diverse cast to tell the old tale, and the choices largely make sense in historical context. Played by a man of Indian descent, the subtle racism and structural disadvantages David faces are all the more searing and impactful when they're based not on happenstance but partially on skin color.If only the story itself was injected with such reimagination. While the costumes and set design are exquisite, there's a stolid and creaky feel to the show that recalls a stuffy theatrical repertory production. Even at its best, Dickens is dense and bulky, and without much effort to recast and slim down the storylines for modern times, it's easy to get hopelessly lost amid the barrage of plodding plot developments.Despite its flaws, the film is a welcome sight for sore, theater-deprived moviegoers jonesing for a reason to grab a soda and bucket of popcorn and get back to the old routine. As David always believes, better things are to come.RATING: 2.5 stars out of 4.This story originally written by Phil Villarreal on KGUN9.com 2119

Older women with excess body fat, even if they have what's considered a normal body-mass index, could be at greater risk for breast cancer, according to a study published Thursday in the medical journal JAMA Oncology."We do find that excess body fat in those who are post-menopausal with a normal body mass index is associated with about a doubling in the risk of estrogen-dependent breast cancer," said Dr. Andrew Dannenberg, one of the study's authors and director of cancer prevention at the Sandra and Edward Meyer Cancer Center at Weill Cornell Medicine.The American Cancer Society says estrogen-dependent cancers, called ER-positive breast cancer in the study, occur when the receptor proteins in or on cells attach to the hormone estrogen and rely on it to grow.The researchers studied 3,460 American women between the ages of 50 and 79 who had gone through menopause. The women were part of the Women's Health Initiative and had their body composition measured at the beginning of that program, Dannenberg said. Of those women, 146 developed ER-positive breast cancer, and the researchers looked for a relationship between excess body fat and the development of this cancer. 1190

来源：资阳报